Identification of Admission High Risk Elderly

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01934426
Collaborator
(none)
760
1
12
63.4

Study Details

Study Description

Brief Summary

Objective: The study aim to establish high risk admission model and readmission model for elderly in Taiwan.

Method: Investigators compare the clinical, epidemiological, and socioeconomic characteristics of admitted patients during 1 August,2011 to 31 July,2012. All patients will follow up to end of study to identify 14 days readmission and 30 days readmission to geriatic ward.

Expected Outcomes: (1) To compare the prediction value of derivation cohort and validation cohort. (2) To identify high risk indicators of admission and readmission for elderly. (3) To determine the risk factors in admission elderly association with quality indicators.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    760 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Identification of Admission High Risk Elderly From Multiple Cohorts: a Pilot Study
    Study Start Date :
    Apr 1, 2013
    Actual Primary Completion Date :
    Feb 1, 2014
    Actual Study Completion Date :
    Apr 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Admission High Risk

    Admission High Risk

    Outcome Measures

    Primary Outcome Measures

    1. Determine percentages of high risk in elderly 14 days readmission to geriatric ward [1-year]

      Readmission in 14 days to geriatric ward is an important issue of elderly.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Patients with age 65 year old above

    2. Patients admission to geriatric ward

    Exclusion Criteria:
    1. Patients with unstable vital sign

    2. Patients or dependants reject to sign inform consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Taiwan University Hospital Taipei Taiwan 100

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Ding-Cheng Chan, MD, PhD, National Taiwan University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT01934426
    Other Study ID Numbers:
    • 201303058RINC
    First Posted:
    Sep 4, 2013
    Last Update Posted:
    Apr 23, 2014
    Last Verified:
    Apr 1, 2014
    Keywords provided by National Taiwan University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 23, 2014